BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6406599)

  • 1. Monoclonal antibody against a differentiation antigen on human leukemia cells: cross-reactivity with rat leukemia and suppression of rat leukemia in vivo.
    Johnson RJ; Shin HS
    J Immunol; 1983 Jun; 130(6):2930-6. PubMed ID: 6406599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decidual cell-specific surface antigen(s) recognized by monoclonal antibodies: tissue and species distribution.
    Kearns M; Parhar RS; Lala PK
    J Immunol; 1985 Aug; 135(2):1046-52. PubMed ID: 2409134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
    Aota F; Chang D; Hill NO; Khan A
    Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel differentiation antigen on proliferating murine thymocytes identified by a rat monoclonal antibody.
    Takei F
    J Immunol; 1984 Feb; 132(2):766-71. PubMed ID: 6418809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
    Martens AC; Johnson RJ; Kaizer H; Hagenbeek A
    Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
    Tanimoto M; Scheinberg DA; Cordon-Cardo C; Huie D; Clarkson BD; Old LJ
    Leukemia; 1989 May; 3(5):339-48. PubMed ID: 2716349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
    Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
    J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody (WI-2) reactive against human transformed and leukemic cells.
    Aota F; Chang D; Hill NO; Khan A
    Jpn J Clin Oncol; 1984 Dec; 14(4):575-84. PubMed ID: 6520969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.
    Civin CI; Strauss LC; Brovall C; Fackler MJ; Schwartz JF; Shaper JH
    J Immunol; 1984 Jul; 133(1):157-65. PubMed ID: 6586833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
    Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation antigens of human hemopoietic cells: patterns of reactivity of two monoclonal antibodies.
    Pessano S; Bottero L; Faust J; Trucco M; Palumbo A; Pegoraro L; Lange B; Brezin C; Borst J; Terhorst C; Rovera G
    Cancer Res; 1983 Oct; 43(10):4812-5. PubMed ID: 6603905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
    Malcolm AJ; Shipman RC; Levy JG
    J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
    Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
    J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies IGR to surface antigens of neutrophilic granulocytes in human blood].
    Ingerpuu SO; Piĭrsoo AO; Siunter AE; Pikhlak AN
    Eksp Onkol; 1990; 12(1):56-60. PubMed ID: 2298145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
    Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
    J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.